{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:15:36Z","timestamp":1791584136802,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.euo.2024.04.002","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:15:21Z","timestamp":1713784521000},"page":"1431-1440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phase 1\/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Gu\u00e9rin in Patients with High-risk Non\u2013muscle-invasive Bladder Cancer"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4207-7490","authenticated-orcid":false,"given":"Sarah P.","family":"Psutka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Veleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Siman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Jannat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Schade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Annen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Greenlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2024.04.002_b0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2017.04.086","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/ASTRO\/SUO guideline","volume":"198","author":"Chang","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0010","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2020.10.039","article-title":"Side effects of intravesical BCG and chemotherapy for bladder cancer: what they are and how to manage them","volume":"149","author":"Koch","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.euo.2024.04.002_b0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0302-2838(03)00371-3","article-title":"The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial","volume":"44","author":"Sylvester","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0025","first-page":"255","article-title":"Management of high-risk non-muscle invasive bladder cancer","volume":"64","author":"Brausi","year":"2012","journal-title":"Minerva Urol Nefrol"},{"key":"10.1016\/j.euo.2024.04.002_b0030","first-page":"157","article-title":"Managing the adverse events of intravesical bacillus Calmette-Gu\u00e9rin therapy","volume":"7","author":"Decaestecker","year":"2015","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0035","first-page":"9480","article-title":"Health-related quality of life after BCG or MMC induction for non-muscle invasive bladder cancer","volume":"25","author":"Siracusano","year":"2018","journal-title":"Can J Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0040","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/CAD.0000000000000775","article-title":"A systematic review of preventive and therapeutic options for symptoms of cystitis in patients with bladder cancer receiving intravesical bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"30","author":"Poletajew","year":"2019","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.euo.2024.04.002_b0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0302-2838(03)00357-9","article-title":"Maintenance bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group phase III trial","volume":"44","author":"van der Meijden","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0050","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2012.10.039","article-title":"Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Gu\u00e9rin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance","volume":"63","author":"Oddens","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0055","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-5347(01)64936-X","article-title":"Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911","volume":"157","author":"Vegt","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0060","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.juro.2006.04.104","article-title":"The effect of ofloxacin on bacillus Calmette-Guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study","volume":"176","author":"Colombel","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0065","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/S0022-5347(01)66040-3","article-title":"The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma","volume":"155","author":"B\u00f6hle","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0070","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.juro.2012.10.070","article-title":"Randomized controlled trial of oxybutynin extended release versus placebo for urinary symptoms during intravesical bacillus Calmette-Gu\u00e9rin treatment","volume":"189","author":"Johnson","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0075","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s00192-015-2935-y","article-title":"The role of acupuncture in managing overactive bladder; a review of the literature","volume":"27","author":"Forde","year":"2016","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.euo.2024.04.002_b0080","doi-asserted-by":"crossref","first-page":"e9838","DOI":"10.1097\/MD.0000000000009838","article-title":"Acupuncture for adults with overactive bladder: A systematic review and meta-analysis of randomized controlled trials","volume":"97","author":"Zhao","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.euo.2024.04.002_b0085","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/acupmed-2017-011528","article-title":"Acupuncture for overactive bladder in adults: a systematic review and meta-analysis","volume":"37","author":"Mak","year":"2019","journal-title":"Acupunct Med"},{"key":"10.1016\/j.euo.2024.04.002_b0090","first-page":"145","article-title":"Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome","volume":"9","author":"de Wall","year":"2017","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.5603\/GP.a2017.0013","article-title":"Complete response to acupuncture therapy in female patients with refractory interstitial cystitis\/bladder pain syndrome","volume":"88","author":"S\u00f6nmez","year":"2017","journal-title":"Ginekol Pol"},{"key":"10.1016\/j.euo.2024.04.002_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2024.04.002_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2022.101044","article-title":"Effects of acupuncture to decrease adverse events in patients with high-risk non-muscle invasive bladder cancer receiving induction intravesical BCG therapy: study protocol for a randomized, controlled pilot and feasibility study","volume":"30","author":"Psutka","year":"2022","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.euo.2024.04.002_b0110","series-title":"Clean needle technique manual for acupuncturists: guidelines and standards for the clean and safe clinical practice of acupuncture","author":"National","year":"2003"},{"key":"10.1016\/j.euo.2024.04.002_b0115","first-page":"256","article-title":"A manual of acupuncture","author":"Deadman","year":"1998","journal-title":"Journal of Chinese Medicine"},{"key":"10.1016\/j.euo.2024.04.002_b0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12906-015-0781-6","article-title":"Acupuncture at homotopic acupoints exerts dual effects on bladder motility in anesthetized rats","volume":"15","author":"Qin","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.euo.2024.04.002_b0125","first-page":"22","article-title":"Uncovering the expectancy effect: the validation of the acupuncture expectancy scale","volume":"16","author":"Mao","year":"2010","journal-title":"Altern Ther Health Med"},{"key":"10.1016\/j.euo.2024.04.002_b0130","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. National Cancer Institute; 2017."},{"key":"10.1016\/j.euo.2024.04.002_b0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2024.04.002_b0140","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.eururo.2014.02.034","article-title":"Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer","volume":"66","author":"Blazeby","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2024.04.002_b0145","doi-asserted-by":"crossref","first-page":"e2241720","DOI":"10.1001\/jamanetworkopen.2022.41720","article-title":"Comparison of acupuncture vs sham acupuncture or waiting list control in the treatment of aromatase inhibitor-related joint pain: a randomized clinical trial","volume":"5","author":"Hershman","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2024.04.002_b0150","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","article-title":"Fourth consensus guidelines for the management of postoperative nausea and vomiting","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth Analg"},{"key":"10.1016\/j.euo.2024.04.002_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2504021","article-title":"Effectiveness of acupuncture for early recovery of bowel function in cancer: a systematic review and meta-analysis","volume":"2017","author":"Liu","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.euo.2024.04.002_b0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ctim.2013.08.020","article-title":"Systematic review of the efficacy of pre-surgical mind-body based therapies on post-operative outcome measures","volume":"21","author":"Nelson","year":"2013","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.euo.2024.04.002_b0165","article-title":"The efficacy of acupuncture in post-operative pain management: a systematic review and meta-analysis","volume":"11","author":"Wu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.euo.2024.04.002_b0170","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1200\/JCO.22.01357","article-title":"Integrative medicine for pain management in oncology: Society for Integrative Oncology-ASCO guideline","volume":"40","author":"Mao","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2024.04.002_b0175","first-page":"13","article-title":"Acupuncture practice, past and present: is it safe and effective?","volume":"4","author":"Lao","year":"2006","journal-title":"J Soc Integr Oncol"},{"key":"10.1016\/j.euo.2024.04.002_b0180","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1200\/JCO.2012.43.5818","article-title":"Systematic review of acupuncture in cancer care: a synthesis of the evidence","volume":"31","author":"Garcia","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2024.04.002_b0185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11255-022-03434-8","article-title":"Mechanism of traditional Chinese medicine in treating overactive bladder","volume":"55","author":"Liao","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euo.2024.04.002_b0190","article-title":"Acupuncture for the treatment of overactive bladder: a systematic review and meta-analysis","volume":"13","author":"Lee","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.euo.2024.04.002_b0195","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2147\/IJGM.S406194","article-title":"Acupuncture for women with overactive bladder: perspective of traditional Chinese medicine and related mechanism","volume":"16","author":"Wang","year":"2023","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.euo.2024.04.002_b0200","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3759069","article-title":"Clinical experiences of Korean medicine treatment against urinary bladder cancer in general practice","volume":"2016","author":"Park","year":"2016","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.euo.2024.04.002_b0205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1001\/archinte.164.1.104","article-title":"Prospective investigation of adverse effects of acupuncture in 97 733 patients","volume":"164","author":"Melchart","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.euo.2024.04.002_b0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13020-020-00388-w","article-title":"A randomized controlled trial to assess the effectiveness and safety of acupuncture for overactive bladder: a study in Hong Kong population","volume":"15","author":"Lin","year":"2020","journal-title":"Chin Med"},{"key":"10.1016\/j.euo.2024.04.002_b0215","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1159\/000524098","article-title":"Quality of life, efficacy, and safety of sequential intravesical gemcitabine + docetaxel versus BCG for non-muscle invasive urinary bladder cancer: a pilot study","volume":"106","author":"Pareek","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2024.04.002_b0220","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.3390\/ijerph191710825","article-title":"Impact of effective intravesical therapies on quality of life in patients with non-muscle invasive bladder cancer: a systematic review","volume":"19","author":"Yuen","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.euo.2024.04.002_b0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.euros.2023.08.004","article-title":"Quality of life in patients with high-grade non-muscle-invasive bladder cancer undergoing standard versus reduced frequency of bacillus Calmette-Gu\u00e9rin instillations: the EAU-RF NIMBUS trial","volume":"56","author":"van Straten","year":"2023","journal-title":"Eur Urol Open Sci"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124000919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931124000919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T19:11:14Z","timestamp":1737832274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931124000919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2588931124000919"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2024.04.002","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase 1\/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Gu\u00e9rin in Patients with High-risk Non\u2013muscle-invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2024.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}